FULCRUM THERAPEUTICS INC (FULC) Stock Analyst Ratings
NASDAQ:FULC - Nasdaq - US3596161097 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to FULC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.72. This target is 11.44% above the current price.
FULC was analyzed by 13 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about FULC.
In the previous month the buy percentage consensus was at a similar level.
FULC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-23 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-05-15 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-14 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-13 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-09-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-09-12 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-12 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-09-12 | Stifel | Downgrade | Buy -> Hold |
| 2024-09-12 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-09-09 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-20 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-03-13 | RBC Capital | Initiate | Outperform |
| 2024-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-26 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-01-25 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-09-25 | Goldman Sachs | Initiate | Neutral |
| 2023-08-23 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-08-22 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-22 | Stifel | Upgrade | Hold -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |